Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2006 1
2008 1
2010 1
2016 2
2018 1
2020 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.
Krämer B, Knoll R, Bonaguro L, ToVinh M, Raabe J, Astaburuaga-García R, Schulte-Schrepping J, Kaiser KM, Rieke GJ, Bischoff J, Monin MB, Hoffmeister C, Schlabe S, De Domenico E, Reusch N, Händler K, Reynolds G, Blüthgen N, Hack G, Finnemann C, Nischalke HD, Strassburg CP, Stephenson E, Su Y, Gardner L, Yuan D, Chen D, Goldman J, Rosenstiel P, Schmidt SV, Latz E, Hrusovsky K, Ball AJ, Johnson JM, Koenig PA, Schmidt FI, Haniffa M, Heath JR, Kümmerer BM, Keitel V, Jensen B, Stubbemann P, Kurth F, Sander LE, Sawitzki B; Deutsche COVID-19 OMICS Initiative (DeCOI); Aschenbrenner AC, Schultze JL, Nattermann J. Krämer B, et al. Among authors: johnson jm. Immunity. 2021 Nov 9;54(11):2650-2669.e14. doi: 10.1016/j.immuni.2021.09.002. Epub 2021 Sep 4. Immunity. 2021. PMID: 34592166 Free PMC article.
Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement.
Young S, Abbasian C, Al-Attar Z, Branney P, Colley B, Cortese S, Cubbin S, Deeley Q, Gudjonsson GH, Hill P, Hollingdale J, Jenden S, Johnson J, Judge D, Lewis A, Mason P, Mukherjee R, Nutt D, Roberts J, Robinson F, Woodhouse E, Cocallis K. Young S, et al. Among authors: johnson j. World J Psychiatry. 2023 Mar 19;13(3):84-112. doi: 10.5498/wjp.v13.i3.84. eCollection 2023 Mar 19. World J Psychiatry. 2023. PMID: 37033892 Free PMC article. Review.
Middle-ear disease and schizophrenia: case-control study.
Mason P, Rimmer M, Richman A, Garg G, Johnson J, Mottram PG. Mason P, et al. Among authors: johnson j. Br J Psychiatry. 2008 Sep;193(3):192-6. doi: 10.1192/bjp.bp.108.052795. Br J Psychiatry. 2008. PMID: 18757975
Necrotizing infection of the heart.
Ballard DH, Pennington GP 2nd, Pennington GP, Johnson J, Bhalla S, Raptis C. Ballard DH, et al. Among authors: johnson j. Clin Imaging. 2018 Sep-Oct;51:111-113. doi: 10.1016/j.clinimag.2018.01.014. Epub 2018 Feb 6. Clin Imaging. 2018. PMID: 29454267 Free PMC article.
Large-scale asymmetric synthesis of a cathepsin S inhibitor.
Lorenz JC, Busacca CA, Feng X, Grinberg N, Haddad N, Johnson J, Kapadia S, Lee H, Saha A, Sarvestani M, Spinelli EM, Varsolona R, Wei X, Zeng X, Senanayake CH. Lorenz JC, et al. Among authors: johnson j. J Org Chem. 2010 Feb 19;75(4):1155-61. doi: 10.1021/jo9022809. J Org Chem. 2010. PMID: 20102230
13 results